Ahmadi A, Argulian E, Leipsic J, Newby DE, Narula J. From subclinical atherosclerosis to plaque progression and acute coronary events: JACC State-of-the-Art review. J Am Coll Cardiol. 2019;74(12):1608–17. https://doi.org/10.1016/j.jacc.2019.08.012.

Article  PubMed  Google Scholar 

Camaré C, Pucelle M, Nègre-Salvayre A, Salvayre R. Angiogenesis in the atherosclerotic plaque. Redox Biol. 2017;12:18–34. https://doi.org/10.1016/j.redox.2017.01.007.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Stone PH, Libby P, Boden WE. Fundamental pathobiology of coronary atherosclerosis and clinical implications for chronic ischemic heart disease Management-The plaque hypothesis: A narrative review. JAMA Cardiol. 2023;8(2):192–201. https://doi.org/10.1001/jamacardio.2022.3926.

Article  PubMed  PubMed Central  Google Scholar 

He H, Han Q, Wang S, Long M, Zhang M, Li Y, Zhang Y, Gu N. Design of a multifunctional nanozyme for resolving the Proinflammatory plaque microenvironment and attenuating atherosclerosis. ACS Nano. 2023;17(15):14555–71. https://doi.org/10.1021/acsnano.3c01420.

Article  CAS  PubMed  Google Scholar 

Ridker PM. Residual inflammatory risk: addressing the obverse side of the atherosclerosis prevention coin. Eur Heart J. 2016;37(22):1720–2. https://doi.org/10.1093/eurheartj/ehw024.

Article  PubMed  Google Scholar 

Ridker PM, Everett BM, Thuren T, MacFadyen JG, Chang WH, Ballantyne C, Fonseca F, Nicolau J, Koenig W, Anker SD, Kastelein JJP, Cornel JH, Pais P, Pella D, Genest J, Cifkova R, Lorenzatti A, Forster T, Kobalava Z, Vida-Simiti L, Flather M, Shimokawa H, Ogawa H, Dellborg M, Rossi PRF, Troquay RPT, Libby P, Glynn RJ. Antiinflammatory therapy with Canakinumab for atherosclerotic disease. N Engl J Med. 2017;377(12):1119–31. https://doi.org/10.1056/NEJMoa1707914.

Article  CAS  PubMed  Google Scholar 

Nidorf SM, Fiolet ATL, Mosterd A, Eikelboom JW, Schut A, Opstal TSJ, The SHK, Xu XF, Ireland MA, Lenderink T, Latchem D, Hoogslag P, Jerzewski A, Nierop P, Whelan A, Hendriks R, Swart H, Schaap J, Kuijper AFM, van Hessen MWJ, Saklani P, Tan I, Thompson AG, Morton A, Judkins C, Bax WA, Dirksen M, Alings M, Hankey GJ, Budgeon CA, Tijssen JGP, Cornel JH, Thompson PL. Colchicine in patients with chronic coronary disease. N Engl J Med. 2020;383(19):1838–47. https://doi.org/10.1056/NEJMoa2021372.

Article  CAS  PubMed  Google Scholar 

Serhan CN, Chiang N, Dalli J. The resolution code of acute inflammation: novel pro-resolving lipid mediators in resolution. Semin Immunol. 2015;27(3):200–15. https://doi.org/10.1016/j.smim.2015.03.004.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Serhan CN, Chiang N. Resolution phase lipid mediators of inflammation: agonists of resolution. Curr Opin Pharmacol. 2013;13(4):632–40. https://doi.org/10.1016/j.coph.2013.05.012.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Kim AS, Conte MS. Specialized pro-resolving lipid mediators in cardiovascular disease, diagnosis, and therapy. Adv Drug Deliv Rev. 2020;159:170–9. https://doi.org/10.1016/j.addr.2020.07.011.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Fredman G, Spite M. Specialized pro-resolving mediators in cardiovascular diseases. Mol Aspects Med. 2017;58:65–71. https://doi.org/10.1016/j.mam.2017.02.003.

Article  PubMed  PubMed Central  Google Scholar 

Fredman G, MacNamara KC. Atherosclerosis is a major human killer and non-resolving inflammation is a prime suspect. Cardiovascular Res. 2021;117(13):2563–74. https://doi.org/10.1093/cvr/cvab309.

Article  CAS  Google Scholar 

Serhan CN. Discovery of specialized pro-resolving mediators marks the dawn of resolution physiology and Pharmacology. Mol Aspects Med. 2017;58:1–11. https://doi.org/10.1016/j.mam.2017.03.001.

Article  PubMed  PubMed Central  Google Scholar 

Djuricic I, Calder PC. Beneficial outcomes of Omega-6 and Omega-3 polyunsaturated fatty acids on human health: an update for 2021. Nutrients. 2021;13(7). https://doi.org/10.3390/nu13072421.

Dyall SC, Balas L, Bazan NG, Brenna JT, Chiang N, da Costa Souza F, Dalli J, Durand T, Galano JM, Lein PJ, Serhan CN, Taha AY. Polyunsaturated fatty acids and fatty acid-derived lipid mediators: recent advances in the Understanding of their biosynthesis, structures, and functions. Prog Lipid Res. 2022;86(101165). https://doi.org/10.1016/j.plipres.2022.101165.

De Caterina R. n-3 fatty acids in cardiovascular disease. N Engl J Med. 2011;364(25):2439–50. https://doi.org/10.1056/NEJMra1008153.

Article  PubMed  Google Scholar 

Tortosa-Caparrós E, Navas-Carrillo D, Marín F, Orenes-Piñero E. Anti-inflammatory effects of Omega 3 and Omega 6 polyunsaturated fatty acids in cardiovascular disease and metabolic syndrome. Crit Rev Food Sci Nutr. 2017;57(16):3421–9. https://doi.org/10.1080/10408398.2015.1126549.

Article  CAS  PubMed  Google Scholar 

Kuhn H, Banthiya S, van Leyen K. Mammalian lipoxygenases and their biological relevance. Biochim Biophys Acta. 2015;1851(4):308–30. https://doi.org/10.1016/j.bbalip.2014.10.002.

Article  CAS  PubMed  Google Scholar 

Haeggström JZ, Funk CD. Lipoxygenase and leukotriene pathways: biochemistry, biology, and roles in disease. Chem Rev. 2011;111(10):5866–98. https://doi.org/10.1021/cr200246d.

Article  CAS  PubMed  Google Scholar 

Harizi H, Corcuff JB, Gualde N. Arachidonic-acid-derived eicosanoids: roles in biology and immunopathology. Trends Mol Med. 2008;14(10):461–9. https://doi.org/10.1016/j.molmed.2008.08.005.

Article  CAS  PubMed  Google Scholar 

Serhan CN, Hamberg M, Samuelsson B. Lipoxins: novel series of biologically active compounds formed from arachidonic acid in human leukocytes. Proc Natl Acad Sci USA. 1984;81(17):5335–9. https://doi.org/10.1073/pnas.81.17.5335.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Chen XS, Kurre U, Jenkins NA, Copeland NG, Funk CD. cDNA cloning, expression, mutagenesis of C-terminal isoleucine, genomic structure, and chromosomal localizations of murine 12-lipoxygenases. J Biol Chem. 1994;269(19):13979–87.

CAS  PubMed  Google Scholar 

Dixon RA, Diehl RE, Opas E, Rands E, Vickers PJ, Evans JF, Gillard JW, Miller DK. Requirement of a 5-lipoxygenase-activating protein for leukotriene synthesis. Nature. 1990;343(6255):282–4. https://doi.org/10.1038/343282a0.

Article  CAS  PubMed  Google Scholar 

Hill E, Maclouf J, Murphy RC, Henson PM. Reversible membrane association of neutrophil 5-lipoxygenase is accompanied by retention of activity and a change in substrate specificity. J Biol Chem. 1992;267(31):22048–53.

CAS  PubMed  Google Scholar 

Samuelsson B, Dahlén SE, Lindgren JA, Rouzer CA, Serhan CN. Leukotrienes and Lipoxins: structures, biosynthesis, and biological effects. Sci (New York NY). 1987;237(4819):1171–6. https://doi.org/10.1126/science.2820055.

Article  CAS  Google Scholar 

Henderson WR Jr. The role of leukotrienes in inflammation. Ann Intern Med. 1994;121(9):684–97. https://doi.org/10.7326/0003-4819-121-9-199411010-00010.

Article  CAS  PubMed  Google Scholar 

Godson C, Guiry P, Brennan E. Lipoxin mimetics and the resolution of inflammation. Annu Rev Pharmacol Toxicol. 2023;63:429–48. https://doi.org/10.1146/annurev-pharmtox-051921-085407.

Article  CAS  PubMed  Google Scholar 

Levy BD, Clish CB, Schmidt B, Gronert K, Serhan CN. Lipid mediator class switching during acute inflammation: signals in resolution. Nat Immunol. 2001;2(7):612–9. https://doi.org/10.1038/89759.

Article  CAS  PubMed  Google Scholar 

Romano M. Lipoxin and aspirin-triggered Lipoxins. ScientificWorldJournal. 2010;10:1048–64. https://doi.org/10.1100/tsw.2010.113.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Roma